Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Regenerative Medicine International (OTCPK:CNRMF) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
China Regenerative Medicine International Quick Ratio Related Terms
China Regenerative Medicine International Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Regenerative Medicine International Quick Ratio Chart
China Regenerative Medicine International Annual Data
For the Biotechnology subindustry, China Regenerative Medicine International's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Regenerative Medicine International Quick Ratio vs Biotechnology Industry
China Regenerative Medicine International Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Regenerative Medicine International (CNRMF) has a Quick Ratio of 1.12 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on China Regenerative Medicine International and its competitors. This is 10% below median its historical median of 1.24. Over the past decade, China Regenerative Medicine International's Quick Ratio has ranged from 0.71 to 5.43. According to the industry distribution chart, China Regenerative Medicine International ranks #1106 out of 1410 companies in the Biotechnology industry, placing it in the top 78.4%.
Is China Regenerative Medicine International's Quick Ratio too high?
China Regenerative Medicine International's current Quick Ratio of 1.12 is 10% below median its 10-year median of 1.24. Over the past 10 years, this metric has ranged from a low of 0.71 to a high of 5.43. The Biotechnology industry median Quick Ratio is 3.58. China Regenerative Medicine International's value of 1.12 is 68.7% below this industry median. Based on the distribution chart, China Regenerative Medicine International ranks #1106 out of 1410 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, China Regenerative Medicine International has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does China Regenerative Medicine International's Quick Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, China Regenerative Medicine International ranks #1106 out of 1410 companies for Quick Ratio. This places China Regenerative Medicine International in the lower half of its industry. The industry median Quick Ratio is 3.58. China Regenerative Medicine International's value of 1.12 is 68.7% below this benchmark. Historically, China Regenerative Medicine International's own Quick Ratio has ranged from 0.71 to 5.43 over the past decade. While the company's 10-year median is 1.24 vs. the industry median of 3.58, China Regenerative Medicine International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.58, based on 1,410 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Regenerative Medicine International's current Quick Ratio of 1.12 is 68.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on China Regenerative Medicine International and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Regenerative Medicine International's current Quick Ratio is 1.12, which is 10% below median its own 10-year median of 1.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Regenerative Medicine International stock overvalued right now?
China Regenerative Medicine International (CNRMF) has a current Quick Ratio of 1.12. The stock's GF Value™ is $0.09, compared to a current price of $0.04 — trading 61.1% below its estimated fair value. The current Quick Ratio is 1.12, which is 10% below median its 10-year median of 1.24 and 68.7% below the Biotechnology industry median of 3.58. China Regenerative Medicine International's overall GF Score™ is 30/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For China Regenerative Medicine International (CNRMF), the current Quick Ratio is 1.12 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Regenerative Medicine International (CNRMF) Overvalued in 2026?
Based on GuruFocus' analysis, China Regenerative Medicine International stock appears to be undervalued.
The current stock price of $0.04 is trading 61.1% below its estimated GF Value™ of $0.09.
Key valuation signals for CNRMF:
Quick Ratio: 1.12 (10% below median its 10-year median of 1.24)
GF Value™: $0.09 vs. price of $0.04 (61.1% below fair value)
Industry Position: 68.7% below the Biotechnology median (#1106 of 1410)
No single metric tells the full story. See the CNRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Regenerative Medicine International Ltd is an investment holding company. The company is engaged in the provision of healthcare products and services. It is engaged in research and development, production and sales of tissue engineering and regenerative medicine products. The business scope of company includes tissue engineering, cosmetics, cell storage, preparation and therapy, hospitals administration and other business division. The segments of the company are Aesthetic medical and beauty services and Medical services. The majority of the company's revenue is derived from its Aesthetic medical and beauty services segment that provides medical beauty products and services. Geographically, the Hong Kong accounts for the majority of the revenue and also has a presence in PRC.
30GF Score
Get the complete analysis for CNRMF
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CNRMF has been successfully added to your 
